The estimated Net Worth of Christine Mundkur is at least 1.79 百万$ dollars as of 28 February 2022. Ms. Mundkur owns over 27,675 units of Mannkind Corp stock worth over 1,560,042$ and over the last 6 years she sold MNKD stock worth over 0$. In addition, she makes 233,777$ as Independent Director at Mannkind Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Mundkur MNKD stock SEC Form 4 insiders trading
Christine has made over 1 trades of the Mannkind Corp stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 27,675 units of MNKD stock worth 74,999$ on 28 February 2022.
The largest trade she's ever made was buying 27,675 units of Mannkind Corp stock on 28 February 2022 worth over 74,999$. On average, Christine trades about 2,516 units every 0 days since 2019. As of 28 February 2022 she still owns at least 254,493 units of Mannkind Corp stock.
You can see the complete history of Ms. Mundkur stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christine Mundkur biography
Christine Mundkur J.D. serves as Independent Director of the Company. Ms. Mundkur most recently served as chief executive officer and the non-voting chairman of the board of directors for Impopharma Inc., a developer of complex formulations focused on inhalation pharmaceutical products. While at Impopharma, Ms. Mundkur led the transition of the company from a successful clinical research organization into a generic pharmaceutical inhalation development company. Her work included the internal development and filing of Abbreviated New Drug Applications of spray and inhalation products. Ms. Mundkur also held leadership positions as president and chief executive office of the US Division and head of commercial operations for North America for Sandoz, Inc. Earlier, she served as chief executive officer of Barr Laboratories, Inc., where she started her career as quality and regulatory counsel. In addition, Ms. Mundkur served as a strategic consultant advising several clients on global pharmaceutical business strategies. Ms. Mundkur holds a J.D. from the St. Louis University School of Law and received her B.S. degree in chemistry from St. Louis University.
What is the salary of Christine Mundkur?
As the Independent Director of Mannkind Corp, the total compensation of Christine Mundkur at Mannkind Corp is 233,777$. There are 12 executives at Mannkind Corp getting paid more, with Michael Castagna having the highest compensation of 1,551,760$.
How old is Christine Mundkur?
Christine Mundkur is 51, she's been the Independent Director of Mannkind Corp since 2018. There are 17 older and 5 younger executives at Mannkind Corp. The oldest executive at Mannkind Corp is Kent Kresa, 82, who is the Independent Chairman of the Board.
What's Christine Mundkur's mailing address?
Christine's mailing address filed with the SEC is 7000, Cardinal Place, Dublin, Washington Township, Franklin County, Ohio, 43017, United States.
Insiders trading at Mannkind Corp
Over the last 20 years, insiders at Mannkind Corp have traded over 14,187,027$ worth of Mannkind Corp stock and bought 107,212,962 units worth 2,707,661,837$ . The most active insiders traders include Alfred E Mann、Juergen Martens、David Thomson. On average, Mannkind Corp executives and independent directors trade stock every 27 days with the average trade being worth of 3,220,647$. The most recent stock trade was executed by Stuart A Tross on 3 September 2024, trading 25,000 units of MNKD stock currently worth 156,500$.
What does Mannkind Corp do?
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
What does Mannkind Corp's logo look like?
Complete history of Ms. Mundkur stock trades at Mannkind Corp、Cardinal Health
Mannkind Corp executives and stock owners
Mannkind Corp executives and other stock owners filed with the SEC include:
-
Michael Castagna,
Chief Executive Officer, Director -
Dr. Michael E. Castagna Pharm.D.,
CEO & Director -
Stuart Tross,
Chief People and Workplace Officer -
David Thomson,
Executive Vice President, General Counsel, Secretary -
Dr. Michael E. Castagna,
CEO & Director -
Steven Binder,
Chief Financial Officer -
Dr. David B. Thomson,
Exec. VP, Gen. Counsel & Sec. -
Joseph Kocinsky,
Chief Technology Officer -
Steven B. Binder,
Chief Financial Officer -
Joseph Kocinsky M.B.A., M.S.,
Chief Technology Officer -
Dr. Stuart A. Tross,
Chief People & Workplace Officer -
Rosabel Alinaya,
Vice President of Investor Relations, Interim Corporate Controller, Treasurer -
Christine Mundkur,
Independent Director -
Kent Kresa,
Independent Chairman of the Board -
Ronald Consiglio,
Independent Director -
Michael Friedman,
Independent Director -
James Shannon,
Independent Director -
Kevin Kaiserman,
Vice President - Medical Affairs and Safety -
Jennifer Grancio,
Independent Director -
Anthony Hooper,
Independent Director -
Alejandro Galindo M.B.A., M.S.,
Chief Commercial Officer -
James Patrick McCauley Jr., J.D., M.B.A.,
Chief Commercial Officer -
John F. Bedard,
Sr. VP of Worldwide Regulatory Affairs -
Rosabel Realica Alinaya,
VP of Investor Relations & Treasury -
Thomas Hofmann M.D., Ph.D.,
Chief Scientific Officer -
Matthew J Pfeffer,
Corporate VP and CFO -
Henry L Nordhoff,
Director -
David Mac Callum,
Director -
Raymond W. Urbanski,
Corp VP, CMO -
David M Kendall,
Chief Medical Officer -
Elizabeth Garrett Ingram,
Chief Marketing Officer -
Courtney Barton,
Chief Compl & Privacy Officer -
Patrick Mc Cauley,
Chief Commercial Officer -
John R. Riesenberger,
VP & Chief Commercial Officer -
Richard L Anderson,
VP & CFO -
Heather Hay Murren,
Director -
Kathleen Connell,
Director -
Llew Keltner,
Director -
Dan Burns,
VP & President, MKBP -
W Wendell Cheatham,
VP, Medical & Reg Affairs -
Juergen Martens,
Corporate VP -
Hakan Edstrom,
President & COO -
Alfred E Mann,
Chairman & CEO -
Diane Palumbo,
Vice President, Human Resource -
Abraham E Cohen,
Director -
Peter C Richardson,
Chief Scientific Officer -
Lauren M Sabella,
EVP Chief Operating Officer -
Alejandro Galindo,
EVP Endocrine Business Unit -
Burkhard Blank,
EVP Chief Medical Officer -
Sanjay R Singh,
EVP Technical Operations -
Christopher B Prentiss,
Chief Financial Officer -
Sabrina Kay,